跳至主要内容
临床试验/IRCT20210117050055N1
IRCT20210117050055N1尚未招募3 期

Effect of synbiotics supplement on fatigue and sleep quality in hemodialysis patients with chronic kidney disease

Sabzevar University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • A patient with a diagnosis of chronic kidney disease who undergoing hemodialysis for at least 3 months.
  • signing informed consent for participation in the study
  • Patient with arteriovenous fistula or permanent catheter or venous arterial graft
  • The patient undergoing hemodialysis 3 times a week for 4 hours each time
  • Patient with KT / V> 1
  • Do not suffer from hearing and vision disorders
  • No neurological disorders and a history of hospitalization in the psychiatric ward
  • age range of 18 to 65 years

排除标准

  • Active infection during the last 30 days
  • Pregnant or lactating mothers
  • Taking antibiotics, prebiotics, probiotics, synbiotics, vitamin supplements or antioxidants during the last 30 days
  • Suffering from autoimmune diseases or connective tissue disorders
  • History of cardiovascular diseases
  • Diabetic foot infection
  • Gastrointestinal diseases (inflammatory bowel disease, ulcerative colitis, Crohn's disease, celiac disease, lactose intolerance or allergy, irritable bowel syndrome)
  • Liver disease (such as hepatitis B, hepatitis C)
  • suffering from various types of malignancies
  • Smoking more than 10 cigarettes per day
  • Participate in other drug interventions
  • hemoglobin less than 8 mg/dl
  • PSQI score less than 6 (good sleep quality)
  • acquisition of CFS score less than 18

研究者

发起方
Sabzevar University of Medical Sciences

相似试验